Heartcore Enterprises, Inc. — Form 8-K Summary
Reporting date: April 24, 2024; filed April 25, 2024. The filing reports a Nasdaq listing compliance matter under Item 8.01, Other Events. Heartcore’s common stock trades on the Nasdaq Capital Market under the symbol HTCR.
Business Context and Reporting Period
Nasdaq previously notified the Company on October 26, 2023 that its common stock had failed to meet the $1.00 minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2), based on the preceding 30 consecutive business days. The initial 180-day compliance period was scheduled to expire on April 23, 2024.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.
Material Changes and Listing Status
- On April 24, 2024, Nasdaq granted the Company an additional 180-day compliance period, ending October 21, 2024.
- The extension was granted because the Company met Nasdaq’s market value of publicly held shares requirement and other initial-listing requirements, except for the minimum bid price requirement.
- The Company provided written notice of its intention to cure the deficiency during the additional period by effecting a reverse stock split, if necessary.
- There was no immediate effect on the listing or trading of HTCR on the Nasdaq Capital Market.
Outlook, Risks, and Unusual Items
- The Company can regain compliance if its closing bid price is at least $1.00 per share for a minimum of 10 consecutive business days during the additional compliance period.
- Nasdaq may provide written confirmation of compliance and close the matter if that condition is satisfied.
- The Company stated that it is monitoring its closing bid price and evaluating alternatives, including a potential reverse stock split.
- There can be no assurance that the Company will regain compliance, even if it continues to satisfy other Nasdaq listing requirements.
Investor Verification Items
- Verify whether HTCR achieved a closing bid price of at least $1.00 for 10 consecutive business days before October 21, 2024.
- Verify whether the Company ultimately implemented a reverse stock split or another measure to cure the deficiency.
- Confirm any subsequent Nasdaq notifications regarding continued listing or delisting proceedings.
- Review subsequent filings for the Company’s financial condition, liquidity, capital structure, and any effects of the listing deficiency.